Home - Products - Cell Cycle/DNA Damage - GPR - Acifran

Acifran

CAS No. 72420-38-3

Acifran( —— )

Catalog No. M33827 CAS No. 72420-38-3

Acifran (AY 25712) is an HM74A/GPR109A and GPR109B agonist and displays antihyperlipidemic activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	73	In Stock
10MG	123	In Stock
25MG	250	In Stock
50MG	398	In Stock
100MG	579	In Stock
200MG	Get Quote	In Stock
500MG	1190	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Acifran
Note

Research use only, not for human use.
Brief Description

Acifran (AY 25712) is an HM74A/GPR109A and GPR109B agonist and displays antihyperlipidemic activity.
Description

Acifran (AY 25712), an antihyperlipidemic agent, is an orally active agonist of GPR109A (HM74A) and GPR109B, the high and low affinity receptors for Niacin.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

GPR
Recptor

GPR
Research Area

——
Indication

——

Chemical Information

CAS Number

72420-38-3
Formula Weight

218.21
Molecular Formula

C12H10O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 125 mg/mL (572.84 mM; Ultrasonic )
SMILES

CC1(OC(=CC1=O)C(O)=O)c1ccccc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. M N Cayen, et al. The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogs. Xenobiotica. 1986 Mar;16(3):251-63. ?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SB271046

SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
CRTh2 antagonist 2

CRTh2 antagonist 2 is a selective and potent CRTH2 antagonist, IC50≤10 nM. CRTh2 antagonist 2 can be used to study the direction of androgenic alopecia.
OX04528

OX04528 is an orally active and potent GPR84 biased agonist.OX04528 inhibits cAMP signaling and may be useful in cancer research.

Sign In Join Free